A detailed history of Gts Securities LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Gts Securities LLC holds 92,300 shares of NVO stock, worth $13.2 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
92,300
Previous 51,700 78.53%
Holding current value
$13.2 Million
Previous $5.35 Million 121.6%
% of portfolio
0.02%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$102.11 - $135.92 $1.33 Million - $1.77 Million
12,992 Added 86.57%
27,999 $3.6 Million
Q4 2023

Feb 14, 2024

BUY
$87.78 - $105.45 $206,283 - $247,807
2,350 Added 18.57%
15,007 $1.55 Million
Q3 2023

Nov 15, 2023

SELL
$90.94 - $199.54 $402,864 - $883,962
-4,430 Reduced 25.93%
12,657 $1.15 Million
Q2 2023

Aug 15, 2023

BUY
$155.98 - $172.65 $2.67 Million - $2.95 Million
17,087 New
17,087 $2.77 Billion

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $322B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Gts Securities LLC Portfolio

Follow Gts Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gts Securities LLC with notifications on news.